The role of amylin in the control of energy homeostasis

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 6, 2010, Pages

  Lutz, Thomas A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Area postrema; Energy expenditure; Hindbrain; Leptin; Trophic effect

Indexed keywords

AMYLIN; LEPTIN;

AREA POSTREMA; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN STEM; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; FOREBRAIN; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; MEAL; METABOLIC REGULATION; NONHUMAN; OBESITY; PARABRACHIAL NUCLEUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SATIETY; SOLITARY TRACT NUCLEUS; WEIGHT CHANGE; WEIGHT GAIN;

AMYLOID; ANIMALS; EATING; ENERGY METABOLISM; HUMANS; RATS; SATIATION;

EID: 77952703708     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00703.2009     Document Type: Review

References (82)

1. Arnelo U, Permert J, Adrian TE, Larsson J, Westermark P, Reidelberger RD. Chronic infusion of IAPP causes anorexia in rats. Am J Physiol Regul Integr Comp Physiol 271: R1654-R1659, 1996.
2. Asarian L. Loss of cholecystokinin and glucagon-like peptide-1 induced satiation in mice lacking the serotonin 2C receptors. Am J Physiol Regul Integr Comp Physiol 296: R51-R56, 2009.
3. Banks WA, Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19: 883-889, 1998.
4. Banks WA. The blood-brain barrier: connecting the gut and the brain. Regul Pept 149: 11-14, 2008.
5. Banks WA. Blood-brain barrier as a regulatory interface. Forum Nutr 63: 102-110, 2010.
6. Barrachina MD, Martinez V, Wang LX, Wei JY, Tachè Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 94: 10455-10460, 1997. (Pubitemid 27407063)
7. Barth SW, Riediger T, Lutz TA, Rechkemmer G. Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor activity modifying proteins in the rat. Brain Res 997: 97-102, 2004. (Pubitemid 38058539)
8. Becskei C, Riediger T, Zünd D, Wookey P, Lutz TA. Immunohistochemical mapping of calcitonin receptors in the adult rat brain. Brain Res 1030: 221-233, 2004. (Pubitemid 39574954)
9. Becskei C, Grabler V, Edwards GL, Riediger T, Lutz TA. Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK. Brain Res 1162: 76-84, 2007. (Pubitemid 47088378)
10. Bhavsar S, Watkins J, Young A. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol Behav 64: 557-561, 1998. (Pubitemid 28458854)
11. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304: 108-110, 2004.
12. Bouret SG, Gorski JN, Patterson CM, Chen S, Levin BE, Simerly RB. Hypothalamic neural projections are premanently disrupted in diet-induced obese rats. Cell Metab 7: 179-185, 2008. (Pubitemid 351181005)
13. Bouret SG. Development of hypothalamic neural networks controlling appetite. Forum Nutr 63: 84-93, 2010.
14. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Strobel S, Wang Y, Burns C, Lush C, Weyer C, Horowitz M. Effect of pramlintide on satiety and food intake in obese subjects. Diabetologia 48: 838-848, 2005.
15. Chavez M, Kaiyala K, Madden LJ, Schwartz MW, Woods SC. Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci 109: 528-531, 1995.
16. Crawley JN, Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 302: 703-706, 1983.
17. Devine E, Young AA. Weight gain in male and female mice with amylin knockout (Abstract). Diabetes 47: A317, 1998.
18. Dobolyi A. Central amylin expression and its induction in rat dams. J Neurochem 111: 1490-1500, 2009.
19. Eiden S, Daniel C, Steinbrück A, Schmidt I, Simon E. Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signaling in laboratory rodents. J Physiol 541: 1041-1048, 2002. (Pubitemid 35190261)
20. Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, Toshimori H, Matsukara S. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15: 97-102, 1992.
21. Fischer JA, Muff R, Born W. Functional relevance of G protein-coupledreceptor-associated proteins, exemplified by receptor-activity- modifying proteins (RAMPs). Biochem Soc Transact 30: 455-460, 2002. (Pubitemid 35001576)
22. Geary N. Endocrine controls of eating: CCK, leptin, and ghrelin. Physiol Behav 81: 719-733, 2004. (Pubitemid 38845039)
23. Grabler V, Lutz TA. Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls. Physiol Behav 81: 481-488, 2004. (Pubitemid 38591537)
24. Hanabusa T, Kubo K, Oki C, Nakano Y, Okai K, Sanke T, Nanjo K. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15: 89-96, 1992.
25. Hillebrand JJ, Geary N. Do leptin and insulin signal adiposity? Forum Nutr 63: 111-122, 2010.
26. Hollander P, Maggs DG, Ruggles JA, Fineman M, Shen L, Kolterman OG, Weyer C. Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients. Obes Res 12: 661-668, 2004. (Pubitemid 41132509)
27. Isaksson B, Wang F, Permert J, Olsson M, Fruin B, Herrington MK, Enochsson L, Erlanson-Albertsson C, Arnelo U. Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis. Pancreatology 5: 29-36, 2005. (Pubitemid 40674587)
28. Leckström A, Lundquist I, Ma Z, Westermark P. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 18: 266-273, 1999. (Pubitemid 29149206)
29. Lutz TA, Riediger T, Rushing PA, Scharrer E. The anorectic effect of amylin and its interaction with other anorectic signals. Neuropeptide Interactions in the Control of Ingestive Behavior, Proceedings of the International Conference on the Physiology of Food and Fluid Intake, 2001.
30. Lutz TA. Amylinergic control of feeding. Physiol Behav 89: 465-471, 2006.
31. Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E. Amylin decreases meal size in rats. Physiol Behav 58: 1197-1202, 1995.
32. Lutz TA, Senn M, Althaus J, Del Prete E, Ehrensperger F, Scharrer E. Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 19: 309-317, 1998.
33. Lutz TA, Mollet A, Rushing PA, Riediger T, Scharrer E. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Int J Obes Relat Metab Disord 25: 1005-1011, 2001.
34. Mack C, Wilson J, Athanacio J, Reynolds J, Laugero K, Guss S, Vu C, Roth J, Parkes D. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 293: R1855-R1863, 2007.
35. Martin L, Siliart B, Lutz T, Biourge V, Nguyen P, Dumon H. Post-prandial response of plasma insulin, amylin and acylated ghrelin to various test meals in lean and obese cats. Br J Nutr 26: 1-10, 2010.
36. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339, 1998.
37. Mollet A, Lutz TA, Meier S, Riediger T, Rushing PA, Scharrer E. Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol 281: R1442-R1448, 2001.
38. Mollet A, Meier S, Grabler V, Gilg S, Scharrer E, Lutz TA. Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin. Peptides 24: 91-98, 2003.
39. Mollet A, Meier S, Riediger T, Lutz TA. Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin. Peptides 24: 155-158, 2003.
40. Mollet A, Gilg S, Riediger T, Lutz TA. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Physiol Behav 81: 149-155, 2004.
41. Morley JE, Flood JF, Horowitz M, Morley PM, Walter MJ. Modulation of food intake by peripherally administered amylin. Am J Physiol 67: R178-R184, 1994.
42. Muff R, Born W, Lutz TA, Fischer JA. Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes. Peptides 25: 2027-2038, 2004.
43. Münzberg H. Leptin-signaling pathways and leptin resistance. Forum Nutr 63: 123-132, 2010.
44. Osaka T, Tsukamoto A, Koyama Y, Inoue S. Central and peripheral administration of amylin induces energy expenditure in anesthetized rats. Peptides 29: 1028-1035, 2008.
45. Osto M, Wielinga PY, Alder B, Walser N, Lutz TA. Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin. Physiol Behav 91: 566-572, 2007.
46. Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Am J Physiol Endocrinol Metab 267: E156-E164, 1994.
47. Potes CS, Lutz TA, Riediger T. Identification of central projections from amylin-activated neurons to the lateral hypothalamus. Brain Res In press.
48. Potes CS, Riediger T, Lutz TA. Noradrenergic neurons of the area postrema mediate amylin's anorectic action [Online]. Appetite 52: 853, 2009.
49. Ravussin E, Smith SR, Mitchell JA, Shringarpure R, Shan K, Maier H, Koda JE, Weyer C. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity 17: 1736-1743, 2009.
50. Reidelberger RD, Haver AC, Arnelo U, Smith DD, Schaffert CS, Permert J. Amylin receptor blockade stimulates food intake in rats. Am J Physiol Regul Integr Comp Physiol 287: R568-R574, 2004.
51. Riediger T, Schmid HA, Lutz T, Simon E. Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol 281: R1833-R1843, 2001.
52. Riediger T, Zünd D, Becskei C, Lutz TA. The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am J Physiol Regul Integr Comp Physiol 286: R114-R122, 2004.
53. Riediger T, Hermann A, Hehl A, Bouret S, Lutz TA. Amylin-deficient mice have decreased fiber density in AP-NTS projections [Online]. Appetite 52: 854, 2009.
54. Riedy CA, Chavez M, Figlewicz DP, Woods SC. Central insulin enhances sensitivity to cholecystokinin. Physiol Behav 58: 755-760, 1995.
55. Rinaman L, Verbalis JG, Stricker EM, Hoffman GE. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express c-Fos following peripheral administration of cholecystokinin. J Comp Neurol 338: 475-490, 1993.
56. Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 147: 5855-5864, 2006.
57. Roth JD, Hughes H, Coffey T, Maier H, Trevaskis JL, Anderson CM. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. Am J Physiol Endocrinol Metab 293: E1112-E1117, 2007.
58. Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE, Anderson CM, Parkes DG, Baron AD. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 105: 7257-7262, 2008.
59. Rowland NE, Richmond RM. Area postrema and the anorectic actions of dexfenfluramine and amylin. Brain Res 820: 86-91, 1999.
60. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC. Amylin: a novel action in the brain to reduce body weight. Endocrinology 141: 850-853, 2000.
61. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, Air EL, Woods SC. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142: 5035-5038, 2001.
62. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL. Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52: 232-238, 2003.
63. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62: 553-567, 1994.
64. Smith GP. Ontogeny of ingestive behavior. Dev Psychobiol 48: 345-359, 2006.
65. Sullivan EL, Grove KL. Metabolic imprinting in obesity. Forum Nutr 63: 186-194, 2010.
66. Surina-Baumgartner DM, Langhans W, Geary N. Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats. Am J Physiol Regul Integr Comp Physiol 269: R978-R982, 1995.
67. Sutton GM, Patterson LM, Berthoud HR. Extracellular signal-regulated kinase 1/2 signaling pathway in solitary nucleus mediates cholecystokinin- induced suppression of food intake in rats. J Neurosci 24: 10240-10247, 2004.
68. Trevaskis JL, Coffey T, Cole R, Lei C, Wittmer C, Walsh B, Weyer C, Koda J, Baron AD, Parkes DG, Roth JD. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 149: 5679-5687, 2008.
69. Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Obesity 18: 21-26, 2010.
70. Turek VF, Trevaskis JL, Levin BE, Dunn-Meynell AA, Irani B, Gu G, Wittmer C, Griffin PS, Vu C, Parkes DG, Roth J. Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 151: 143-152, 2010.
71. Ueda T, Ugawa S, Saishin Y, Shimada S. Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. Brain Res Mol Brain Res 93: 36-45, 2001.
72. West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol Regul Integr Comp Physiol 246: R776-R787, 1984.
73. Weyer C, Vozarova B, Ravussin E, Tataranni PA. Changes in energy metabolism in response to 48 h of overfeeding and fasting in Caucasians and Pima Indians. Int J Obes 25: 593-600, 2001.
74. Wielinga PY, Alder B, Lutz TA. The acute effect of amylin and salmon calcitonin on energy expenditure. Physiol Behav 91: 212-217, 2007.
75. Wielinga PY, Löwenstein C, Muff S, Munz M, Woods SC, Lutz TA. Central amylin acts as an adiposity signal to control body weight and energy expenditure. Physiol Behav. In press.
76. Williams DL, Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 135: 1320-1325, 2005.
77. Woods SC. Gastrointestinal satiety signals. I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol 286: G7-G13, 2004.
78. Woods SC. Signals that influence food intake and body weight. Physiol Behav 86: 709-716, 2005.
79. Woods SC, Lutz TA, Geary N, Langhans W. Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci 361: 1219-1235, 2006.
80. Wookey PJ, Lutz TA, Andrikopoulos S. Amylin in the periphery II. Sci World J 6: 1642-1655, 2007.
81. Young A, Denaro M. Roles of amylin in diabetes and in regulation of nutrient load. Nutrition 14: 524-527, 1998.
82. Young A. Amylin and the integrated control of nutrient flux. Adv Pharmacol 52: 67-77, 2005.